Significance of NS3 and NS5 antigens in screening for HCV antibody

Can restoring tidal wetlands reduce estuarine nuisance flooding of coasts under future sea-level rise?

Earth's future·2025

Validation of a scanning technique with minimal compression for measuring muscle volume with freehand 3D ultrasound.

Journal of biomechanics·2023

Use of analgesics in France, following dextropropoxyphene withdrawal.

BMC health services research·2018

Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients.

Transplantation proceedings·2017

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients.

Mathematical medicine and biology : a journal of the IMA·2017

Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.

Journal of viral hepatitis·2016

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Emerging roles of apolipoprotein E4 in cerebral small vessel disease-related cognitive impairment: mechanistic insights and therapeutic perspectives.

Frontiers in human neuroscience·2026

From past to present and toward the future: a mechanism-informed clinical framework for COVID-19-associated headache and post-viral pain.

Frontiers in neurology·2026

Somatotopic functional connectivity gradients in the monkey and human striatum.

Imaging neuroscience (Cambridge, Mass.)·2026

Corrigendum to "Diffusion MRI-based analysis of functional alterations of the glymphatic system in children with non-lesional epilepsy" [Neuroimag. Rep. 2025 5(1) 100237].

Neuroimage. Reports·2026

Across established non-invasive neuromodulation and emerging deep-targeting strategies: a comparative bibliometric analysis of TI, TMS, tDCS, and tFUS/TUS/LIFU.

Frontiers in neuroscience·2026

Computational approaches to deep learning-driven EEG analysis for neurological disease diagnosis: a systematic review.

Frontiers in neuroinformatics·2026

Related Experiment Videos

Significance of NS3 and NS5 antigens in screening for HCV antibody

Related Concept Videos

Can restoring tidal wetlands reduce estuarine nuisance flooding of coasts under future sea-level rise?

Validation of a scanning technique with minimal compression for measuring muscle volume with freehand 3D ultrasound.

Use of analgesics in France, following dextropropoxyphene withdrawal.

Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients.

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients.

Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Emerging roles of apolipoprotein E4 in cerebral small vessel disease-related cognitive impairment: mechanistic insights and therapeutic perspectives.

From past to present and toward the future: a mechanism-informed clinical framework for COVID-19-associated headache and post-viral pain.

Somatotopic functional connectivity gradients in the monkey and human striatum.

Corrigendum to "Diffusion MRI-based analysis of functional alterations of the glymphatic system in children with non-lesional epilepsy" [Neuroimag. Rep. 2025 5(1) 100237].

Across established non-invasive neuromodulation and emerging deep-targeting strategies: a comparative bibliometric analysis of TI, TMS, tDCS, and tFUS/TUS/LIFU.

Computational approaches to deep learning-driven EEG analysis for neurological disease diagnosis: a systematic review.

Related Experiment Videos

Significance of NS3 and NS5 antigens in screening for HCV antibody

Related Concept Videos

Related Articles